FDA Says It’s The Law, Denies Petition Requesting GDUFA Fee Payment Changes
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency also says only Congress could enact fee waivers and exemptions, but Square Pharmaceuticals indicates it will join lobbying efforts to create them.
You may also be interested in...
Generic User Fee 'Relief' For Small Firms Would Mean Bigger Bills For Large One
Talks between industry and FDA focus on size of the discount and how a small business would be defined.
Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree
Small business owners say the GDUFA facility and other fees are too expensive, especially while waiting for ANDAs to be approved, but any small business waiver is unlikely until GDUFA II.
GDUFA Facility Fees Should Be Waived Until First ANDA Approved, Petition Argues
Bangladesh-based Square Pharmaceuticals says the fees are burdensome for first-time filers, given long approval times, but the firm’s citizen petition strategy may further delay approval of its ANDA.